These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 29308904)
1. PET Imaging of VCAM-1 Expression and Monitoring Therapy Response in Tumor with a Zhang X; Liu C; Hu F; Zhang Y; Wang J; Gao Y; Jiang Y; Zhang Y; Lan X Mol Pharm; 2018 Feb; 15(2):609-618. PubMed ID: 29308904 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Zhang X; Hu F; Liu C; Yin L; Zhang Y; Zhang Y; Lan X Contrast Media Mol Imaging; 2018; 2018():7832805. PubMed ID: 29853809 [TBL] [Abstract][Full Text] [Related]
3. PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody. Lv G; Sun X; Qiu L; Sun Y; Li K; Liu Q; Zhao Q; Qin S; Lin J J Nucl Med; 2020 Jan; 61(1):117-122. PubMed ID: 31253743 [TBL] [Abstract][Full Text] [Related]
4. Novel single-chain variant of antibody against mesothelin established by phage library. Yakushiji H; Kobayashi K; Takenaka F; Kishi Y; Shinohara M; Akehi M; Sasaki T; Ohno E; Matsuura E Cancer Sci; 2019 Sep; 110(9):2722-2733. PubMed ID: 31461572 [TBL] [Abstract][Full Text] [Related]
5. Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide. Liu Q; Pan D; Cheng C; Zhang A; Ma C; Wang L; Zhang D; Liu H; Jiang H; Wang T; Xu Y; Yang R; Chen F; Yang M; Zuo C Nucl Med Biol; 2015 Dec; 42(12):939-44. PubMed ID: 26344861 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis, and Biological Evaluation of Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911 [TBL] [Abstract][Full Text] [Related]
7. In Vivo Evaluation and Dosimetry Estimate for a High Affinity Affibody PET Tracer Targeting PD-L1. Rubins DJ; Meng X; McQuade P; Klimas M; Getty K; Lin SA; Connolly BM; O'Malley SS; Haley H; Purcell M; Gantert L; Holahan M; Lindgren J; Eklund P; Ekblad C; Frejd FY; Hostetler ED; González Trotter DE; Evelhoch JL Mol Imaging Biol; 2021 Apr; 23(2):241-249. PubMed ID: 33098025 [TBL] [Abstract][Full Text] [Related]
8. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. Brand C; Longo VA; Groaning M; Weber WA; Reiner T Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631 [TBL] [Abstract][Full Text] [Related]
9. [ Zhang P; Zhao Z; Zhang L; Wu W; Xu Y; Pan D; Wang F; Yang M Nucl Med Biol; 2019; 74-75():19-24. PubMed ID: 31450071 [TBL] [Abstract][Full Text] [Related]
10. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting. Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611 [TBL] [Abstract][Full Text] [Related]
11. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384 [TBL] [Abstract][Full Text] [Related]
12. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer. England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843 [TBL] [Abstract][Full Text] [Related]
13. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
14. Gallium-68-labeled anti-HER2 single-chain Fv fragment: development and in vivo monitoring of HER2 expression. Ueda M; Hisada H; Temma T; Shimizu Y; Kimura H; Ono M; Nakamoto Y; Togashi K; Saji H Mol Imaging Biol; 2015 Feb; 17(1):102-10. PubMed ID: 25049073 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis. Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330 [TBL] [Abstract][Full Text] [Related]
16. Noninvasive Detection of HER2 Expression in Gastric Cancer by Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865 [TBL] [Abstract][Full Text] [Related]
17. Preclinical Evaluation of [ Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706 [TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of [ Liang Y; Wang X; Chen Y; Zeng X; Liu J; Zhao Z; Yang H; Zhang Q; Li J; Guo Z; Zhang X Mol Pharm; 2024 Oct; 21(10):4960-4969. PubMed ID: 39279392 [TBL] [Abstract][Full Text] [Related]
19. Effects of PEGylation on Imaging Contrast of Wan Q; Yuan H; Cai P; Liu Y; Yan T; Wang L; Zhou Z; Zhang W; Liu N Mol Pharm; 2024 Sep; 21(9):4430-4440. PubMed ID: 39069891 [TBL] [Abstract][Full Text] [Related]
20. In vivo characterization of 68Ga-NOTA-VEGF 121 for the imaging of VEGF receptor expression in U87MG tumor xenograft models. Kang CM; Kim SM; Koo HJ; Yim MS; Lee KH; Ryu EK; Choe YS Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):198-206. PubMed ID: 23096079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]